🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Uterine Sarcoma

A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) NCT03017573NA6 sites📍 Bordeaux📍 Lille📍 Lyon Institut Curie · Tests: Tumor biopsies / Tumor surgery, Blood withdrawal cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881n/a17 sites📍 Duarte📍 Miami📍 Gainesville Adela, Inc Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies NCT07064018Phase 1, Phase 21 site📍 Orange University of California, Irvine · Tests: Spedox-6, Pegfilgrastim, Filgrastim Distance-Based Exercise to Preserve Function and Prevent Disability NCT07059884NA23 sites📍 Dublin📍 Fremont📍 Fresno Alliance for Clinical Trials in Oncology · Tests: Exercise intervention, Telemedicine, Aerobic Exercise Intervention, Exercise Intervention, Accelerometry A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors NCT06508307Phase 11 site📍 Zhengzhou GONGCHU Biotechnology Co., Ltd · Tests: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patients With Advanced Solid Tumors A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation NCT07458347Phase 19 sites📍 Los Angeles📍 Sarasota📍 Tampa Kestrel Therapeutics, Inc. · Tests: KST-6051, Gemcitabine/nab-paclitaxel, Cetuximab, Pembrolizumab, mFOLFOX6 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors NCT07189871Phase 1, Phase 25 sites📍 Dothan📍 Grand Rapids📍 Omaha Radiopharm Theranostics, Ltd · Tests: 177Lu-BetaBart, BetaBart + unlabeled BetaBart Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites📍 Greenwood Village📍 Manchester📍 Daytona Beach University of Nebraska A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites📍 Los Angeles📍 Grand Rapids📍 Lake Success MacroGenics · Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion, Pembrollizumab, vobramitamab tavatecan Ph 2 Elacestrant in ER Positive Uterine Sarcomas NCT07467772Phase 21 site📍 Boston Dana-Farber Cancer Institute · Tests: Elacestrant IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies NCT07197554Phase 16 sites📍 Duarte📍 Newport Beach📍 Boston SEED Therapeutics, Inc. · Tests: ST-01156 Observational Study on Endometrial Stromal Tumors NCT02829437n/a13 sites📍 Meldola📍 Milan📍 Milan Italian Sarcoma Group · Tests: Treatment for EST A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) NCT06760819Phase 254 sites📍 Birmingham📍 Duarte📍 Fort Myers Bayer · Tests: BAY2927088 Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer NCT05646316Phase 360 sites📍 Washington D.C.📍 Coral Gables📍 Deerfield Beach NRG Oncology · Tests: Biospecimen Collection, Diagnostic Imaging Testing, Excisional Biopsy, Indocyanine Green Solution, Minimally Invasive S… Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) NCT03624244Phase 222 sites📍 Besançon📍 Bordeaux📍 Caen Centre Leon Berard · Tests: Aromatase Inhibitors Specimen and Data Study for Ovarian Cancer Early Detection and Prevention NCT00005095n/a1 site📍 Chicago Northwestern University · Tests: Ca-125, screening questionnaire administration, Surgery AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) NCT06004011NA1 site📍 Lusaka Implenomics · Tests: ARROW strategies, One-time education A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors NCT06531486Phase 11 site📍 Beijing Shanghai Fosun Pharmaceutical Industrial Development Co. Lt… · Tests: XS-02 capsules A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites📍 Santa Monica📍 New Have📍 Camperdown Kivu Bioscience Inc. · Tests: KIVU-107 International PPB/DICER1 Registry NCT03382158n/a1 site📍 Minneapolis Children's Hospitals and Clinics of Minnesota Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites📍 Beverly Hills📍 Los Angeles📍 Palo Alto Pheast Therapeutics · Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors NCT04851119Phase 1, Phase 221 sites📍 Birmingham📍 Los Angeles📍 Orange Children's Oncology Group · Tests: Biospecimen Collection, Dual X-ray Absorptiometry, Tegavivint, X-Ray Imaging Early Ageing During Therapy in AYA Cancer Patients NCT05062707n/a1 site📍 Groningen University Medical Center Groningen · Tests: Blood sampling Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers NCT06967961NA1 site📍 Toulouse Institut Claudius Regaud · Tests: For each enrolled patient, the sample described below will be collected as specific intervention intended for research …
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy